{
  "questions": [
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/39555889"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39555889",
          "text": "RankMHC: Learning to Rank Class-I Peptide-MHC Structural Models.. The binding of peptides to class-I Major Histocompability Complex (MHC) receptors and their subsequent recognition downstream by T-cell receptors are crucial processes for most mult...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.2638596296310425,
          "rerank_position": 1
        }
      ],
      "id": "67d74cde18b1e36f2e00003c",
      "type": "summary",
      "body": "Describe RankMHC"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/9703812",
        "http://www.ncbi.nlm.nih.gov/pubmed/29738323",
        "http://www.ncbi.nlm.nih.gov/pubmed/26161418",
        "http://www.ncbi.nlm.nih.gov/pubmed/32285464",
        "http://www.ncbi.nlm.nih.gov/pubmed/30930275",
        "http://www.ncbi.nlm.nih.gov/pubmed/19690479",
        "http://www.ncbi.nlm.nih.gov/pubmed/34799073",
        "http://www.ncbi.nlm.nih.gov/pubmed/2160569",
        "http://www.ncbi.nlm.nih.gov/pubmed/17827054",
        "http://www.ncbi.nlm.nih.gov/pubmed/21575109"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9703812",
          "text": "[Growth and development of colorectal cancer with subclassification on submucosa and proper muscle infiltrating cancer].. Colorectal cancer (CRC) infiltrating the submucosa (sm cancer) and the proper muscle (mp cancer) represent an early and an in...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.40677061676979065,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29738323",
          "text": "Impact of absence of consensual cutoff time distinguishing between synchronous and metachronous metastases: illustration with colorectal cancer.. Staging is essential for scientific exchanges on colorectal cancer. Lack of a consensual definition f...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.4033953845500946,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26161418",
          "text": "Which Metrics Are Appropriate to Describe the Value of New Cancer Therapies?. Patients with certain cancers are treated with curative intent, but for others the results are less favorable and different therapeutic approaches are needed. Early data...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.38361895084381104,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32285464",
          "text": "Impact on colorectal cancer pathology reporting practice of migration from TNM 5 to TNM 8.. AIMS: The introduction of TNM 8 into UK pathology practice in January 2018 considers tumour deposits in colorectal cancer staging for the first time. The i...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.3825414776802063,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30930275",
          "text": "Clinical and Molecular Features of Post-Colonoscopy Colorectal Cancers.. BACKGROUND & AIMS: Post-colonoscopy colorectal cancers (PCCRCs) may arise from missed lesions or due to molecular features of tumors that allow them to grow rapidly. We aimed...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.38080286979675293,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19690479",
          "text": "Identification of the methylator (serrated) colorectal cancer phenotype through precursor serrated polyps.. PURPOSE: Colorectal cancers arise via cumulative genetic and molecular changes that cause mucosal instability, premalignant polyps, and mal...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.3789459764957428,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34799073",
          "text": "Is colorectal neoplasia more aggressive in the young? A look at shifting guidelines.. BACKGROUND: This study aimed to compare factors associated with CRC in patients younger than 50 and in those 50 and older, that required surgical resection due t...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.37876108288764954,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2160569",
          "text": "Evidence for the existence of different types of large bowel tumor: suggestions from the clinical data of a population-based registry.. The clinical findings of a population-based colorectal tumor registry have been analyzed to determine elements ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.37871140241622925,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17827054",
          "text": "Etiologic impact of known cancer susceptibility genes.. The impact of a gene variant on the population burden of cancer can be measured by the population attributable fraction (PAF), which depends on the risk conferred by the variant, genotype rel...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.37681329250335693,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21575109",
          "text": "Validation analysis of Japanese histological classification of breast cancer using the National Summary of Hospital Cancer Registry 2007, Japan.. Using the National Summary of Hospital Cancer Registry 2007, Japan, (HCRJ) from 219 local core cancer...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.3724483847618103,
          "rerank_position": 10
        }
      ],
      "id": "65f7741fc4010b4d78000027",
      "type": "factoid",
      "body": "What proportion of colorectal cancer cases are not assignable to any of the consensus molecular subtype (CMS) groups?"
    },
    {
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/35137964",
        "http://www.ncbi.nlm.nih.gov/pubmed/2824571",
        "http://www.ncbi.nlm.nih.gov/pubmed/26229258",
        "http://www.ncbi.nlm.nih.gov/pubmed/36861059",
        "http://www.ncbi.nlm.nih.gov/pubmed/10102831",
        "http://www.ncbi.nlm.nih.gov/pubmed/39159988",
        "http://www.ncbi.nlm.nih.gov/pubmed/28392833",
        "http://www.ncbi.nlm.nih.gov/pubmed/30922682",
        "http://www.ncbi.nlm.nih.gov/pubmed/29942375",
        "http://www.ncbi.nlm.nih.gov/pubmed/21385473"
      ],
      "snippets": [
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35137964",
          "text": "Will the Pharmacologically Meaningful Half-Life Please Stand Up?",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 64,
          "rerank_score": 0.5442758202552795,
          "rerank_position": 1
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2824571",
          "text": "Could you please review what is currently known about drug half-life and efficacy in light of recent advances in receptor theory?",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 129,
          "rerank_score": 0.482998788356781,
          "rerank_position": 2
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26229258",
          "text": "Keep it short and simple, please!!",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 34,
          "rerank_score": 0.37997961044311523,
          "rerank_position": 3
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36861059",
          "text": "It is time to end our love affair with short-acting Î²2-agonists in asthma? Yes.. Why not directly eradicate SABA from asthma management? The time to leave behind SABA in asthma management is now. We wasted enough time identifying the key issue in ...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.3736024796962738,
          "rerank_position": 4
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10102831",
          "text": "Pleasing both authors and readers. A combination of short print articles and longer electronic ones may help us do this.",
          "beginSection": "title",
          "endSection": "title",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 120,
          "rerank_score": 0.36361557245254517,
          "rerank_position": 5
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/39159988",
          "text": "Why nuclease free water ruined my experiment (but at least it was free), or why the short dash matters.. There are different types of punctuation marks that are referred to as dashes. These include the short dash or hyphen (-), the en dash (-) and...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.341677725315094,
          "rerank_position": 6
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28392833",
          "text": "Surgeons, sign your site!. Please see related Short report: https://pssjournal.biomedcentral.com/articles/10.1186/s13037-017-0125-1.",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 132,
          "rerank_score": 0.2980412244796753,
          "rerank_position": 7
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30922682",
          "text": "Retraction notice to \"Population pharmacokinetic and pharmacodynamic analysis of bosutinib\" [Drug Metab Pharmacokinet 29 (2014) 441-448].. This article [1] has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.c...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.2802765369415283,
          "rerank_position": 8
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29942375",
          "text": "Turning the Page to Year 2016.. As we conclude another year (2015), Volume 2 completed, we are pleased with the number of quality published manuscripts. We are also excited to announce Nanobiomedicine has been indexed in DOAJ (Directory of Open Ac...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.27990293502807617,
          "rerank_position": 9
        },
        {
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21385473",
          "text": "Thromboembolism.. INTRODUCTION: Deep venous thrombosis (DVT) or pulmonary embolism may occur in almost 2 in 1000 people each year, with up to 25% of those having a recurrence. Around 5% to 15% of people with untreated DVT may die from pulmonary em...",
          "beginSection": "abstract",
          "endSection": "abstract",
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "rerank_score": 0.2754088044166565,
          "rerank_position": 10
        }
      ],
      "id": "67cc973e81b1027333000011",
      "type": "list",
      "body": "Please list the short half life Phosphodiesterase 5 inhibitors."
    }
  ]
}